ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
DiagnosesAtorvastatin

Atorvastatin

ICD-10 Coding for Atorvastatin Use and Adverse Effects(T46.6X5A, Z79.899, Z91.130)

PRIMARY SPECIALTYCardiology
COMPLEXITYHigh
LAST UPDATED09/15/2025
Sam Tuffun, PT, DPT
Physical Therapist | Medical Coding & Billing Contributor

Diagnosis Overview

What is Atorvastatin?
Essential facts and insights about Atorvastatin Use and Adverse Effects

Key Clinical Considerations:

  • Patients may present with elevated LDL cholesterol levels, which is a primary indicator for atorvastatin use.
  • Lipid panel results showing total cholesterol, LDL, HDL, and triglycerides are essential for diagnosis and treatment monitoring.
  • Physical examination may reveal signs of cardiovascular disease, such as hypertension or peripheral artery disease.
  • Imaging studies like carotid ultrasound may show plaque buildup, indicating atherosclerosis.
  • Severity of hyperlipidemia can be classified based on LDL levels: mild (130-159 mg/dL), moderate (160-189 mg/dL), and severe (≥190 mg/dL).

Clinical Information

Clinical Criteria & Documentation Requirements

  • Medical records must document the patient's lipid levels, treatment rationale, and any adverse effects experienced.
  • Specific terminology such as 'hyperlipidemia', 'atherosclerosis', and 'statin therapy' should be used.
  • Examples include documenting the initiation of atorvastatin therapy and the patient's response to treatment.
  • Medical necessity must be established through documentation of cardiovascular risk factors and previous treatment failures.
  • Quality measures may include documenting lipid levels before and after atorvastatin initiation.

Coding Guidelines

Usage Guidelines & Examples

  • Use T46.6X5A for adverse effects of atorvastatin when a patient experiences side effects like myopathy or liver enzyme elevation.
  • Do not use Z79.899 for patients not on long-term atorvastatin therapy or those without a history of hyperlipidemia.
  • Compare with E78.5 (hyperlipidemia, unspecified) for patients not specifically treated with atorvastatin.
  • Common errors include using the wrong code for adverse effects; ensure the correct T46.6X5A code is applied for side effects.
  • In complex cases, consider the patient's full medication history and any co-morbid conditions when selecting codes.

Code Exclusions

Important Exclusions

  • Exclude patients with known statin intolerance or those with active liver disease.
  • Alternative codes for excluded conditions include K76.0 (fatty liver disease) for patients with liver issues.
  • Conditions are excluded due to the risk of exacerbating liver damage or muscle disorders.
  • Common mistakes include misclassifying patients with statin intolerance under atorvastatin adverse effects.
  • Related but distinct conditions may include rhabdomyolysis (M62.82) which can occur with statin use.

Related ICD-10 Codes

Primary Codes
T46.6X5A
Adverse effects of atorvastatin, initial encounter
Z79.899
Other long-term drug therapy
Ancillary Codes
Z79.899
Differential Codes
T46.6X5D

Related CPT Codes

CPT codes will be available in a future update.

Specialty Focus

Primary Specialty

Cardiology

Specialty Applications

  • This applies to patients diagnosed with hyperlipidemia or at risk for cardiovascular disease.
  • Patient populations include adults, particularly those over 40, with risk factors such as obesity or family history.
  • Clinical settings include outpatient cardiology clinics and inpatient settings for acute coronary syndrome.
  • Specialty-specific applications are relevant in cardiology and endocrinology.
  • Treatment contexts include primary prevention in high-risk patients and secondary prevention post-myocardial infarction.

Coding Complexity

High Complexity

This diagnosis requires careful attention to:

  • Comprehensive clinical documentation
  • Accurate code selection based on clinical criteria
  • Proper exclusion considerations
  • Specialty-specific coding guidelines

Documentation

Documentation Templates

Template 1

Template: 'Patient diagnosed with hyperlipidemia based on lipid panel results showing elevated LDL levels.'

Template 2

Template: 'Clinical presentation consistent with cardiovascular risk including hypertension and elevated cholesterol.'

Template 3

Template: 'Diagnostic criteria for hyperlipidemia met as evidenced by lipid panel results.'

Template 4

Template: 'Treatment plan initiated for hyperlipidemia with atorvastatin 20 mg daily.'

Template 5

Template: 'Follow-up care for hyperlipidemia including monitoring of lipid levels every 3 months.'

Billing Information

Billing Considerations

  • Ensure proper documentation for billing
  • Verify code specificity requirements
  • Check for any additional codes needed
  • Review payer-specific guidelines

Common Issues

  • Insufficient clinical documentation
  • Incorrect code selection
  • Missing supporting diagnoses
  • Timing and frequency documentation

Frequently Asked Questions

What documentation is required for this diagnosis?

Document lipid levels, treatment rationale, and any adverse effects.

How does this differ from similar diagnoses?

Atorvastatin is specifically for managing cholesterol levels, while other medications may target different lipid profiles.

What are common billing considerations?

Ensure medical necessity is documented to optimize reimbursement for atorvastatin therapy.

What procedures are typically associated?

Related CPT codes may include lipid panel tests and cardiovascular risk assessments.

Are there any quality reporting implications?

Quality measures include monitoring lipid levels and documenting treatment outcomes.